Kyorin Holdings says integration of production function
Dec 19(Reuters) - Kyorin Holdings Inc <4569.T>:Says its Tokyo-based drug unit, which was established in October, will take over Noshiro plant of unit Kyorin Pharmaceutical Company, Limited and manufacture division of KYORIN Rimedio Co.,Ltd., effective April 1, 2018.Says the Tokyo-based drug unit will merge with the company's Shiga-based unit KYORIN Pharmaceutical Facilities Co.,Ltd, effective April 1, 2018.Says KYORIN Pharmaceutical Facilities Co.,Ltd will be dissolved after the merger .
Latest Key Developments inPharmaceuticals
- Tianjin Tianyao Pharmaceuticals Elects Zhang Jie As Chairman
- Onxeo Announces Positive Intermediate Results From First Part Of DRIIV-1B Study Evaluating Asidna™ In Combination With Chemotherapy
- 3Sbio Inc Says Clinical Trial Application Of Group's Drug Approved
- Apellis Pharmaceuticals Says Currently Enrolling Two Global Confirmatory Phase 3 Studies For Patients With GA